Stock Track | Tandem Diabetes Care Soars 9.64% After-Hours on Better-Than-Expected Q1 Results

Stock Track05-08

Tandem Diabetes Care's stock surged 9.64% in after-hours trading following the release of its first-quarter financial results, which showed significant improvement across key metrics.

The medical device company reported Q1 sales of $247.2 million, representing a 5% year-over-year increase, while its net loss narrowed to $20.4 million from wider losses in previous periods. Gross margin climbed 4.8 percentage points to 55%, demonstrating improved operational efficiency.

The company also reported strong operational performance with pump shipments exceeding 29,000 worldwide, including more than 19,000 in the US market. Tandem Diabetes Care reaffirmed its full-year 2026 sales outlook of $1.065 billion to $1.085 billion and projected gross margin of 56%-57%.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1193177303?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-08 04:33","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1193177303","market":"hk","top_or_hot":-1,"title":"Stock Track | Tandem Diabetes Care Soars 9.64% After-Hours on Better-Than-Expected Q1 Results","media":"Stock Track","content":"<p>Tandem Diabetes Care's stock surged 9.64% in after-hours trading following the release of its first-quarter financial results, which showed significant improvement across key metrics.</p><p>The medical device company reported Q1 sales of $247.2 million, representing a 5% year-over-year increase, while its net loss narrowed to $20.4 million from wider losses in previous periods. Gross margin climbed 4.8 percentage points to 55%, demonstrating improved operational efficiency.</p><p>The company also reported strong operational performance with pump shipments exceeding 29,000 worldwide, including more than 19,000 in the US market. Tandem Diabetes Care reaffirmed its full-year 2026 sales outlook of $1.065 billion to $1.085 billion and projected gross margin of 56%-57%.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Tandem Diabetes Care Soars 9.64% After-Hours on Better-Than-Expected Q1 Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Tandem Diabetes Care Soars 9.64% After-Hours on Better-Than-Expected Q1 Results\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-05-08 04:33</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Tandem Diabetes Care's stock surged 9.64% in after-hours trading following the release of its first-quarter financial results, which showed significant improvement across key metrics.</p><p>The medical device company reported Q1 sales of $247.2 million, representing a 5% year-over-year increase, while its net loss narrowed to $20.4 million from wider losses in previous periods. Gross margin climbed 4.8 percentage points to 55%, demonstrating improved operational efficiency.</p><p>The company also reported strong operational performance with pump shipments exceeding 29,000 worldwide, including more than 19,000 in the US market. Tandem Diabetes Care reaffirmed its full-year 2026 sales outlook of $1.065 billion to $1.085 billion and projected gross margin of 56%-57%.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TNDM","symbol_name":"Tandem Diabetes","start_time":0,"source_url":"","article_id":"1193177303","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1193177303","pubTimestamp":1778185989,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Tandem Diabetes Care's stock surged 9.64% in after-hours trading following the release of its first-quarter financial results, which showed significant improvement across key metrics.The medical...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"TNDM":"Tandem Diabetes"},"translate_title":"个股追踪|Tandem Diabetes Care盘后飙升9.64%，Q1业绩好于预期","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TNDM":1},"content_text":"Tandem Diabetes Care's stock surged 9.64% in after-hours trading following the release of its first-quarter financial results, which showed significant improvement across key metrics.The medical device company reported Q1 sales of $247.2 million, representing a 5% year-over-year increase, while its net loss narrowed to $20.4 million from wider losses in previous periods. Gross margin climbed 4.8 percentage points to 55%, demonstrating improved operational efficiency.The company also reported strong operational performance with pump shipments exceeding 29,000 worldwide, including more than 19,000 in the US market. Tandem Diabetes Care reaffirmed its full-year 2026 sales outlook of $1.065 billion to $1.085 billion and projected gross margin of 56%-57%.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1193177303","isCrawlerRequest":true}